Journal of Pathology and Translational Medicine

Case Study

Colloid Carcinoma of the Uterine Cervix and Its Immunohistochemical Analysis: A Case Report: Nermin Koc, Sevcan Arzu Arinkan, Nurver Ozel Ozbay, Selcuk Selcuk; J Pathol Transl Med. 2018;52(1):56-60. Published online January 15, 2018; DOI: https://doi.org/10.4132/jptm.2017.04.08

6,791 View
133 Download

Abstract PDF: Colloid carcinoma, which is a very rare tumor of the uterine cervix, is composed of an excessive amount of mucus and a relative paucity of tumoral glandular cells within them. Herein, we report a rare case of colloid carcinoma of the cervix with adenocarcinoma in situ (AIS), intestinal and usual types, and endocervical adenocarcinoma (usual type) components. We also discuss the morphological and immunohistochemical characteristics of this tumor. A 51-year-old woman was referred to our outpatient clinic with the symptom of genital bleeding lasting for 5 months. She had a cervix surrounded by an irregular tumor with a diameter of 5 cm. The colloid carcinoma cells were positive for MUC2, MUC5AC, and cytokeratin (CK) 7, focal positive for CDX2, and negative for MUC6 and CK20. Also, the intestinal type AIS showed a similar staining pattern. Colloid carcinoma cells producing mucin showed an intestinal phenotype and AIS. The intestinal type can be considered as a precursor lesion of colloid carcinoma.

Original Article

Comparison of the Classical Method and SEE-FIM Protocol in Detecting Microscopic Lesions in Fallopian Tubes with Gynecological Lesions: Nermin Koc, Selçuk Ayas, Sevcan Arzu Arinkan; J Pathol Transl Med. 2018;52(1):21-27. Published online August 19, 2016; DOI: https://doi.org/10.4132/jptm.2016.06.17

11,820 View
400 Download
21 Web of Science
24 Crossref

Background
The objective of this study was to compare the classical method and Sectioning and Extensively Examining the Fimbriated End Protocol (SEE-FIM) in detecting microscopic lesions in fallopian tubes with gynecological lesions. Methods: From a total of 1,118 cases, 582 with various parts of both fallopian tubes sampled in three-ring-shape sections and 536 sampled with the SEE-FIM protocol were included in this study. Pathological findings of cases with endometrial carcinoma, non-uterine pelvic malignant tumor, ovarian borderline tumors, premalignancy, and benign lesions were compared. Results: We detected two tubal infiltrative carcinomas among 40 uterine endometrioid adenocarcinomas, 15 serous tubal intraepithelial carcinomas in 39 non-uterine pelvic serous high-grade carcinoma cases, seven papillary tubal hyperplasias in 13 serous borderline tumor cases, and 11 endometriotic foci and four adenomatoid tumors among all cases sampled with the SEE-FIM protocol. Using the classical method, we detected only one serous tubal intraepithelial carcinoma in 113 non-uterine pelvic serous high-grade carcinoma cases and two papillary tubal hyperplasia cases in 31 serous borderline tumors. We did not identify additional findings in 185 uterine endometrioid carcinoma cases, and neither endometriotic focus nor adenomatoid tumor was shown in other lesions by the classical method. Conclusions: Benign, premalignant, and malignant lesions can possibly be missed using the classical method. The SEE-FIM protocol should be considered especially in cases of endometrial carcinoma, nonuterine pelvic serous cancers, or serous borderline ovarian tumors. For other lesions, at least a detailed examination of the fimbrial end should be undertaken.

Citations

Citations to this article as recorded by

Volumetric sonographic depiction of the fallopian tube lumen for the early detection of tubal abnormalities: A work in progress
Jessica P. Miller, Ryan G. Morrison, Emily Mechling, Karen Tisdale, Katherine Frederick-Dyer, Brannan B. Griffin, Ben H. Park, Lauren S. Prescott, Marta A. Crispens, Ronald Alvarez, Arthur Fleischer
WFUMB Ultrasound Open.2024; 2(1): 100031. CrossRef
ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease
J.A. Ledermann, X. Matias-Guiu, F. Amant, N. Concin, B. Davidson, C. Fotopoulou, A. González-Martin, C. Gourley, A. Leary, D. Lorusso, S. Banerjee, L. Chiva, D. Cibula, N. Colombo, S. Croce, A.G. Eriksson, C. Falandry, D. Fischerova, P. Harter, F. Joly, C
Annals of Oncology.2024; 35(3): 248. CrossRef
Incidental Serous Tubal Intraepithelial Carcinoma Finding in a Nepalese Patient Undergoing Opportunistic Salpingectomy and the Discovery of a BRCA1 Pathogenic Variant
Kristin M. Tischer, Siddhartha Yadav, Debra Bell, Kathleen Hansen, Larissa N. Veres, Brandon Maddy, Jamie N. Bakkum-Gamez
O&G Open.2024; : 009. CrossRef
Prevention of Ovarian Cancer: Where are We Now and Where are We Going?
Isabel V. Rodriguez, Talayeh Ghezelayagh, Kathryn P. Pennington, Barbara M. Norquist
Current Oncology Reports.2024; 26(11): 1355. CrossRef
Prophylactic Radical Fimbriectomy with Delayed Oophorectomy in Women with a High Risk of Developing an Ovarian Carcinoma: Results of a Prospective National Pilot Study
Eric Leblanc, Fabrice Narducci, Gwenaël Ferron, Audrey Mailliez, Jean-Yves Charvolin, El Houssein, Frédéric Guyon, Virginie Fourchotte, Eric Lambaudie, Agathe Crouzet, Yves Fouche, Sébastien Gouy, Pierre Collinet, Frédéric Caquant, Christophe Pomel, Franç
Cancers.2023; 15(4): 1141. CrossRef
Consensus based recommendations for the diagnosis of serous tubal intraepithelial carcinoma: an international Delphi study
Joep M A Bogaerts, Majke H D van Bommel, Rosella P M G Hermens, Miranda P Steenbeek, Joanne A de Hullu, Jeroen A W M van der Laak, Michiel Simons
Histopathology.2023; 83(1): 67. CrossRef
Quality of life after risk-reducing surgery for breast and ovarian cancer prevention: a systematic review and meta-analysis
Xia Wei, Samuel Oxley, Michail Sideris, Ashwin Kalra, Adam Brentnall, Li Sun, Li Yang, Rosa Legood, Ranjit Manchanda
American Journal of Obstetrics and Gynecology.2023; 229(4): 388. CrossRef
Adherence to risk-reducing salpingo-oophorectomy guidelines among gynecologic oncologists compared to general gynecologists
Pegah Blustein, Sarah R. Werner, Pooja Uppalapati, Tung Ming Leung, Gregg A. Husk, Elena B. Pereira, Jill S. Whyte, Jeannine A. Villella
American Journal of Obstetrics and Gynecology.2023; 229(3): 280.e1. CrossRef
Intraluminal tumor cells and prognostic accuracy of endometrial cancer stage criteria: A multi-institution study
Ashley S. Felix, Jennifer A. Sinnott, David E. Cohn, Máire A. Duggan, Laura J. Havrilesky, Alexander B. Olawaiye, Andrea Mariani, Monica Rodriquez, Mary Anne Brett, Giorgia Dinoi, Caitlin E. Meade, Bobbie Hall, Ester Goldfeld, Esther Elishaev, Mark E. She
Gynecologic Oncology.2023; 178: 130. CrossRef
Recommendations for diagnosing STIC: a systematic review and meta-analysis
Joep M. A. Bogaerts, Miranda P. Steenbeek, Majke H. D. van Bommel, Johan Bulten, Jeroen A. W. M. van der Laak, Joanne A. de Hullu, Michiel Simons
Virchows Archiv.2022; 480(4): 725. CrossRef
Magnetic resonance imaging findings of extrauterine high-grade serous carcinoma based on new pathologic criteria for primary site assignment
Masaya Kawaguchi, Hiroki Kato, Yuichiro Hatano, Hiroyuki Tomita, Akira Hara, Tatsuhiko Miyazaki, Masayuki Matsuo
Acta Radiologica.2021; 62(5): 687. CrossRef
Role of Routine Peritoneal Biopsies During Risk Reducing Salpingo-Oophorectomy (RRSO)
Therese Pross, Maria Margarete Karsten, Jens-Uwe Blohmer, Dorothee Speiser
Geburtshilfe und Frauenheilkunde.2021; 81(09): 1031. CrossRef
Histomorphological Spectrum of Incidentally Detected Fallopian Tube Lesions in Patients Operated for Various Clinical Conditions and Detection of Precursor Lesion by Applying Sectioning and Extensively Examining the Fimbriated End Sampling Protocol
Neha Singh, Ipsita Dhal, Aneesha Mohanpuria, Swati Saxena
Oncology Journal of India.2021; 5(3): 85. CrossRef
Risk-reducing Bilateral Salpingo-oophorectomy: Assessing the Incidence of Occult Ovarian Cancer and Surgeon Adherence to Recommended Practices
Laura K. Newcomb, Coralee T. Toal, Noah B. Rindos, Li Wang, Suketu M. Mansuria
Journal of Minimally Invasive Gynecology.2020; 27(7): 1511. CrossRef
Serous Tubal Intraepithelial Carcinoma: A Concise Review for the Practicing Pathologist and Clinician
S. Emily Bachert, Anthony McDowell, Dava Piecoro, Lauren Baldwin Branch
Diagnostics.2020; 10(2): 102. CrossRef
An Alternate Diagnostic Algorithm for the Diagnosis of Intraepithelial Fallopian Tube Lesions
Marie E. Perrone, Nicholas P. Reder, Sergay N. Agoff, Rochelle L. Garcia, Kathy J. Agnew, Barbara M. Norquist, Kathryn P. Pennington, Elizabeth M. Swisher, Mark R. Kilgore
International Journal of Gynecological Pathology.2020; 39(3): 261. CrossRef
Inherited mutations in fallopian tube, ovarian and primary peritoneal carcinoma: Changes in diagnoses and mutational frequency over 20 years
Arielle S. Weiss, Elizabeth Swisher, Kathryn P. Pennington, Marc Radke, Nithisha Khasnavis, Rochelle L. Garcia, Mark R. Kilgore, Ming K. Lee, Barbara M. Norquist
Gynecologic Oncology.2020; 159(1): 214. CrossRef
Grossing Issues in Ovarian and Fallopian Tube Pathology
Lakshmi Shree Kulumani Mahadevan, Byoung Uk Park, I-Tien Yeh
AJSP: Reviews and Reports.2020; 25(4): 174. CrossRef
Ovarian Serous Carcinoma: A Retrospective Study of Clinicopathological Findings and Postchemotherapy Changes
Navatha Vangala, Shantveer G Uppin, Megha S Uppin, Tara Roshni Paul, G Sadashivudu
Indian Journal of Medical and Paediatric Oncology.2020; 41(05): 663. CrossRef
Sectioning and extensively examining the fimbriated end (SEE‐FIM) of the fallopian tube in routine practices, is it worth the effort?
Natthawadee Laokulrath, Malee Warnnissorn, Tuenjai Chuangsuwanich, Suchanan Hanamornroongruang
Journal of Obstetrics and Gynaecology Research.2019; 45(3): 665. CrossRef
Endometrial Carcinoma, Grossing and Processing Issues: Recommendations of the International Society of Gynecologic Pathologists
Anais Malpica, Elizabeth D. Euscher, Jonathan L. Hecht, Rouba Ali-Fehmi, Charles M. Quick, Naveena Singh, Lars-Christian Horn, Isabel Alvarado-Cabrero, Xavier Matias-Guiu, Lynn Hirschowitz, Máire Duggan, Jaume Ordi, Vinita Parkash, Yoshiki Mikami, M. Ruhu
International Journal of Gynecological Pathology.2019; 38(Supplement): S9. CrossRef
Screening and surgical prophylaxis for hereditary cancer syndromes with high risk of endometrial and ovarian cancer
Alexandra S. Bercow, Eric L. Eisenhauer
Journal of Surgical Oncology.2019; 120(5): 864. CrossRef
Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations
George U Eleje, Ahizechukwu C Eke, Ifeanyichukwu U Ezebialu, Joseph I Ikechebelu, Emmanuel O Ugwu, Onyinye O Okonkwo
Cochrane Database of Systematic Reviews.2018;[Epub] CrossRef
Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations
George U Eleje, Ahizechukwu C Eke, Ifeanyichukwu U Ezebialu, Joseph I Ikechebelu, Emmanuel O Ugwu, Onyinye O Okonkwo
Cochrane Database of Systematic Reviews.2016;[Epub] CrossRef

First
Prev
Page of 1
Next
Last

Search